Grants and Contributions:
Title:
Development of Assay Strategies
Agreement Number:
994245
Agreement Value:
$74,998.00
Agreement Date:
Aug 15, 2022 - Aug 31, 2023
Description:
This project will identify specific diagnostic platforms that will be used to measure the presence of biomarkers in human samples. These biomarkers are linked to muscular atrophy.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Bedford, Nova Scotia, CA B4B 0X6
Reference Number:
172-2022-2023-Q2-994245
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
763313665
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 32 days.
Amendment Date
Jul 7, 2023
Recipient's Legal Name:
Myomar Molecular Inc.
Federal Riding Name:
Halifax West
Federal Riding Number:
12006
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171
Amendments: